Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   Novel protection-deprotection strategies in diazeniumdiolate chemistry: synthesis of V-IPA/NO
  2. Nandurdikar, R. S.; Keefer, L. K.; Saavedra, J. E.
  3. Chemical Communications. 2011, Jun 21; 47(23): 6710-6712.
  1. 2.   A Boost for the Emerging Field of RNA Nanotechnology Report on the First International conference on RNA Nanotechnology
  2. Shukla, G. C.; Hague, F.; Tor, Y.; Wilhelmsson, L. M.; Toulme, J. J.; Isambert, H.; Guo, P. X.; Rossi, J. J.; Tenenbaum, S. A.; Shapiro, B. A.
  3. Acs Nano. 2011, May; 5(5): 3405-3418.
  1. 3.   Ionic liquid mediated synthesis of 5-halouracil nucleosides: key precursors for potential antiviral drugs
  2. Kumar, V.; Malhotra, S. V.
  3. Nucleosides, nucleotides & nucleic acids. 2009, Sep; 28(9): 821-34.
  1. 4.   Synthesis and conformational analysis of locked carbocyclic analogues of 1,3-diazepinone riboside, a high-affinity cytidine deaminase inhibitor
  2. Ludek, O. R.; Schroeder, G. K.; Liao, C.; Russ, P. L.; Wolfenden, R.; Marquez, V. E.
  3. Journal of Organic Chemistry. 2009, Aug 21; 74(16): 6212-23.
  1. 5.   Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery
  2. Thomas, J. D.; Majumdar, S.; Sloan, K. B.
  3. Molecules (Basel, Switzerland). 2009 14(10): 4231-45.
  1. 6.   Synthesis of conformationally locked carbocyclic 1,3-diazepinone nucleosides as inhibitors of cytidine deaminase
  2. Ludek, O. R.; Schroeder, G. K.; Wolfenden, R.; Marquez, V. E.
  3. Nucleic acids symposium series (2004). 2008 (52): 659-60.
  1. 7.   Synthesis of conformationally locked carbocyclic nucleoside phosphonates to probe the active site of HIV-1 RT
  2. Saneyoshi, H.; Vu, B. C.; Hughes, S. H.; Boyer, P. L.; Sarafianos, S. G.; Marquez, V. E.
  3. Nucleic acids symposium series (2004). 2008 (52): 623-4.
  1. 8.   Human defensins: synthesis and structural properties
  2. Pazgier, M.; Li, X.; Lu, W.; Lubkowski, J.
  3. Current Pharmaceutical Design. 2007 13(30): 3096-3118.
  1. 9.   Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics
  2. Sun, H. Y.; Nikolovska-Coleska, Z.; Chen, J. Y.; Yang, C. Y.; Tomita, Y.; Pan, H. G.; Yoshioka, Y.; Krajewski, K.; Roller, P. P.; Wang, S. M.
  3. Bioorganic & Medicinal Chemistry Letters. 2005, FEB 1; 15(3): 793-797.
  1. 10.   Synthetic tRNA(Lys,3) as the replication primer for the HIV-1(HXB2) and HIV-1(Mal) genomes
  2. Miller, J. T.; Khvorova, A.; Scaringe, S. A.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2004 32(15): 4687-4695.
  1. 11.   Chemical synthesis and biological properties of pyridine epothilones
  2. Nicolaou, K. C.; Scarpelli, R.; Bollbuck, B.; Werschkun, B.; Pereira, M. M. A.; Wartmann, M.; Altmann, K. H.; Zaharevitz, D.; Gussio, R.; Giannakakou, P.
  3. Chemistry & Biology. 2000 7(8): 593-599.
  1. 12.   Structure-based design of HIV protease inhibitors: pharmacokinetic optimization
  2. Stinson, S. F.; Randad, R. S.; Clanton, D.; House, T.; Lubkowska, L.; Erickson, J. W.
  3. HIV Pathogenesis and Treatment Conference. 1998, 56 (abstract no. 2039).
  1. 13.   Activity of Tethered Human Immunodeficiency Virus 1 Protease Containing Mutations in the Flap Region of One Subunit
  2. Tozser, J.; Yin, F. H.; Cheng, Y. S. E.; Bagossi, P.; Weber, I. T.; Harrison, R. W.; Oroszlan, S.
  3. European Journal of Biochemistry. 1997 244(1): 235-241.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel